Central nervous system damage during HIV infection

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 18, Issue 10, 1996, Pages 707-722

  Lombardi, V R M ^a   Maneiro, E ^a   Cacabelos, R ^a  

^a Centro de Investigacion Biomedica EuroEspes   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BEHAVIOR; CENTRAL NERVOUS SYSTEM; COGNITION; DEMENTIA; ENCEPHALITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENINGITIS; MOTOR PERFORMANCE; MYELITIS; OPPORTUNISTIC INFECTION; RETROVIRUS INFECTION; REVIEW; TOXOPLASMOSIS;

AIDS DEMENTIA COMPLEX; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; BRAIN; HIV INFECTIONS; HIV-1; HIV-2; MICE; RATS;

EID: 0030499559     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (121)

1. Poiesz, B.J., Ruscetti, F.W., Gazdar, A.F. et al. Detection and Isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980, 77: 7415-9.
2. Kalyanaraman, V.S., Sarnagadharan, M.D., Robert-Guroff, M. et al. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982, 218: 571-3.
3. Barre-Sinoussi, F., Chermann, J.C., Rey, F. et al. Isolation of a T-lymphotropic retrovirus from a panent al risk for acquired immune deficiency syndrome (AIDS). Science 1983, 220: 1209-11.
4. Gallo, R.C., Salahuddin, S.Z., Popovic, M. et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) front patients with AIDS and at risk for AIDS. Science 1984, 224: 500-3.
5. Clavel, F., Guetard, D., Brun-Vezinet, F. et al. Isolation of a new human retrovirus from West African patients with AIDS. Science 1986, 233: 343-6.
6. The T- and B-Cell Malignancy Study Group. Statistical analyses of clinico-pathological, virological, and epidemiological data on lymphoid malignancies with special reference to adult T-cell leukemia lymphoma: A report of second nationwide study of Japan. Jpn J Clin Oncol 1985, 15: 517-35.
7. Yoshida, M., Osarne, M., Kawai, H. et al. Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol 1989, 26: 331-5.
8. Furukawa, Y., Fujisawa, J., Osarne, M. et al. Frequent clonal proliferation of human T-cell leukemia virus type I (HTLV-I)-infected T cells in HTLV-I associated myelopathy (HAM-TSP). Blood 1992, 80: 1012-6.
9. Murphy, E.L., Engstrom, J.W., Miller, K., Sacher, R.A., Bush, M.P., Hollingsworth, C.G. and The Reds Investigators. HTLV-II associated myelopathy in a 43-year-old woman. Lancet 1993, 341: 757-8.
10. Burney, A.C., Bruck, H., Chantrenne, Y. et al. Bovine leukemia virus: Molecular biology and epidemiology. In: Viral Oncology. Raven Press: New York 1980, 231-89.
11. Franchini, G., Gurgo, C., Guo, H.G. et al. Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses. Nature 1987, 328: 539-43.
12. Fukasawa, M., Miura, T., Hasegawa, A. et al. Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group. Nature 1988, 333: 457-61.
13. Korlnik, I.J., Boeri, E., Saxinger, W.C. et al. Phylogenetic associations of human and simian T-cell leukemia lymphotropic virus type I strains: Evidence for interspecies transmission. J Virol 1994, 68: 2693-707.
14. Song, K.J., Nerukar, V.R., Saitou, N. et al. Genetic analysis and molecular phytogeny of Simian T-cell lymphotropic virus type I: Evidence for independent virus evolution in Asia and Africa. Virology 1994, 199: 56-66.
15. Wei, X.P., Ghosh, S.K., Taylor, M.E. et al. Viral dynamics in human immunodeficiency virus type I infection. Nature 1995, 373: 117-22.
16. Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M., Markowitz, M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-I infection. Nature 1995, 373: 123-6.
17. Hahn, S., Gehri, R., Erb, P. Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol Rev 1995, 146: 57-79.
18. McArthur, J.C., Hoover, D.R., Bacellar, M.A. et al. Dementia in AIDS patients: Incidence and risk factors. Neurology 1993, 43: 2245-52.
19. Naucler, A., Andreasson, P.A., Mendes Costa, C. et al. HIV-2-associated AIDS and HIV-2 seroprevalence in Bissau, Guinea-Bissau. J AIDS 1989, 2: 88-93.
20. Awa, N., Coll, A.M., Hane, A. et al. HIV seroprevalence among hospitalised patients in Dakar, Senegal. VI Conf AIDS. (June 20-24, San Francisco) 1990, 2: 231.
21. Canas-Ferreira, W., Costa, C., Pinto, A.S. et al. Correlation between in vim HIV-2 replication markers and the clinical stage of infection in seropositive people from Guinea-Bissau (West Africa). VI Conf AIDS. (June 20-24, San Francisco) 1990, 1: 296.
22. Goedert, J.J., Biggar, R.J., Melbye, M. et al. Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with HIV. JAMA 1987, 257: 331-4.
23. Polk, B.F., Fox, R., Brookmeyer, R. et al. Predictors of AIDS developing in a cohort of seropositive homosexual men. New Engl J Med 1987, 316: 61-6.
24. Center for Disease Control. Classification system of HTLV-III/LAV infections. MMWR 1986, 35: 334-8.
25. Goedert, J.J., Biggar, R.J., Weiss, S.H. et al. Three-year incidence of AIDS in five cohorts of HTLV-III infected risk group members. Science 1986, 231: 992-5.
26. Moss, A.R., Bacchetti, P., Osmond, D. et al. Seropositivity for HIV and the development of AIDS or ARC: Three year follow-up of the San Francisco General Hospital cohort. Br Med J 1988, 296: 745-50.
27. Cooper, D.A., Tindall, B., Wilson, E.J. et al. Characterization of T lymphocyte responses during primary infection with human immunodeficiency virus. J Infect Dis 1988, 157: 889-96.
28. Lombardi, V.R.M., Gómez Carrillo, M., Alimandi, M., Boxaca, M., Rossi, P., Libonatti, O. Overt and latent HIV-1 and HTLV-I infection in cohorts of high risk individuals in Argentina. Mol Cell Probes 1991, 409-17.
29. Selik, R.M., Starcher, E.T., Curran, J.W. Opportunistic diseases reported in AIDS patients: Frequencies, associations and trends. AIDS 1987, 1: 175-82.
30. Sunderam, G., McDonald, R.J., Maniatis, T. et al. Tuberculosis as a manifestation of AIDS. JAMA 1986, 256: 362-6.
31. Barrio, E., Carballo, E., Cabarcos, A. The risk of active tuberculosis in HIV-infected anergic patients. An indication for chemoprophylaxis. VI Eur Cong Clin Microbiol Infect Dis (March, Sevilla) 1993, Abst 1116.
32. Bronniman, D.A., Adam, R.D., Calgiani, J.N. et al. Coccidioidomycosis in AIDS. Ann Intern Med 1987, 106: 372-9.
33. Wheat, L.J., Small, C.B. Disseminated histoplasmosis in AIDS. Arch Intern Med 1984, 144: 2147-9.
34. Ferenczy, A., Mitao, M., Nagai, N. et al. Latent papilloma virus and recurring genital warts. New Engl J Med 1985, 313: 784-8.
35. Safai, B., Johnson, K.G., Myskowski, P.L. et al. The natural history of KS in AIDS. Ann Intern Med 1985, 103: 744-50.
36. Mintz, L., Drew, L., Miner, R.C. et al. CMV infection in homosexual men. Ann Intern Med 1983, 99: 326-9.
37. Drew, W.L. Cytomegalovirus infection in patients with AIDS. Clin Infect Dis 1992, 14: 608-15.
38. Pardo, V, Meneses, R., Jaffe, D.J. et al. AIDS-related glomerulopathy: Occurrence in specific risk groups. Kidney Int 1987, 31: 1167-73.
39. Sigurdsson, B. Observations on three slow infections of sheep: maedi; paratuberculosis: rida; a slow encephalitis of sheep, with general remarks on infections which develop slowly and some of their special characteristics. Br Vet J 1954, 110: 255-70, 307-22, 341-54.
40. Narayan, O., Griffin, D.E., Silverstein, A.M. Slow virus injection: Replication and mechanisms of persistence of visna virus in sheep. J Infect Dis 1977, 135: 800-6.
41. Petursson, G., Nathanson, N., Georgsson, G., Panitch, H., Palsson, P.A. Pathogenesis of visna. I. Sequential virologic, serologic and pathologic studies. Lab Invest 1976, 35: 402-12.
42. Nathanson, N., Panitch, H., Palsson, P.A., Petursson, G., Georgsson, G. Pathogenesis of visna. II. Effects of immunosuppression upon early central nervous system lesions. Lab Invest 1976, 35: 444-51.
43. Narayan, O., Griffin, D.E., Clements, J.E. Virus mutation during "slow infection": Temporal development and characterization of mutants of visna virus recovered from sheep. J Gen Virol 1978, 41: 343-52.
44. Clements, J.E., Pedersen, F.S., Narayan, O., Haseltine, W.A. Genomic changes associated with antigenic variation of visna virus during persistent infection. Proc Natl Acad Sci USA 1980, 77: 4454-8.
45. Haase, A.T., Stowring, L., Narayan, O., Griffin, D.E., Price, D. Slow persistent infection caused by visna virus: Role of host restriction. Science 1977, 195: 175-7.
46. Stavrou, D., Deutschlander, N., Dahme, E. Granulomatous encephalomyelitis in goats. J Comp Pathol 1969, 79: 393-6.
47. Cork, L.C., Hudlow, W.J., Gorham, J.R., Piper, R.C., Crawford, T.B. Pathology of viral leukoencephalomyelitis of goats. Acta Neuropathol 1974, 29: 281-92.
48. Cork, L.C., Narayan, O. The pathogenesis of viral leukoencephalomyelitis-arthritis of goats. I. Persistent virai infection with progressive pathological changes. Lab Invest 1980, 42: 596-602.
49. Gardner, M.B. Retroviral spongiform polioencephalomyelopathy. Rev Infect Dis 1985, 7: 99-110.
50. Wong, P.K.Y., Knupp, C., Yuen, P.H., Soong, M.M., Zachary, J.F., Tompkins, W.A.F. Ts1, a paralytogenic mutant of Moloney murine leukemia virus TB, has an enhanced activity to replicate in the central nervous system and primary nerve cell culture. J Virol 1985, 55: 760-7.
51. Szurek, P.F., Yuen, P.M., Jerzy, R., Wong, P.K.Y. Identification of point mutations in the envelope gene of Moloney murine leukemia virus TB temperature-sensitive paralytogenic mutant ts1: Molecular determinants for neurovirulence. J Virol 1988, 62: 357-60.
52. Roman, G.C., Spencer, P.S., Schoenberg, B.S. Tropical myeloneuropathies: The hidden endemias. Neurology 1985, 35: 1158-70.
53. Vernant, J.C., Maurs, L., Gessain, A. et al. Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: A clinical and seroepidemiological study of 25 cases. Ann Neurol 1987, 21: 123-30.
54. Yoshida, M., Miyoshi, I., Hinuma, Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982, 79: 2031-5.
55. Osame, M., Matsumoto, M., Usuku, K. et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I und adult T-cell leukemia like cells. Ann Neurol 1987, 21: 117-22.
56. Kure, K., Lyman, W.D., Weidenheim, K.M., Dickson, D.W. Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using cm improved double-labeling immunohistochemical method. Am J Pathol 1990, 136: 1085-92.
57. Pang, S., Koyanagi, Y., Miles, S., Wiley, C. Vinters, H., Chen, I.S.Y. The structure of HIV-DNA in brain and blood of AIDS patients. Nature 1990, 343: 85-90.
58. Koyanagi, Y., Miles, S., Mitsuyasu, R.T., Merrill, J.E., Vinters, H. V., Chen, I.S.Y. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 1987, 236: 819-22.
59. Eilbott, D.J., Peress, N., Burger, H. et al. Human immunodeficiency virus type I in spinal cords of acquired immune deficiency syndrome patients with myelopathy: Expression and replication in macrophages. Proc Natl Acad Sci USA 1989, 86: 3337-41.
60. Wiley, C.A., Schreier, R.D., Nelson, J.A., Lampert, P.W., Oldstone, M.B.A. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986, 83: 7089-93.
61. Ho, D.D., Rota, T.R., Hirsch, M.S. Infection of monocytes/ macrophages by human T-lymphotropic virus type III. J Clin Invest 1986, 77: 1712-5.
62. Wong-Staal, F., Gallo, R.C. Human T-lymphotropic retroviruses. Nature 1985, 317: 395-403.
63. Maddon, P.J., Dalgleish, A.G., McDougal, J.S., Clapham, P.R., Weiss, R.A., Axel, R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system und the bruin. Cell 1986, 47: 333-48.
64. Mann, D.L., Gartner, S., LeSane, F., Buchow, H., Popovic, M. HIV-1 transmission and function of virus infected monocytes/macrophages. J Immunol 1990, 144: 2152-8.
65. Dewhurst, S., Stevenson, M., Volsky, D.J. Expression of the T4 molecule (AIDS virus receptor) by human brain derived cells. FEBS Lett 1987, 213: 133-7.
66. Funke, I., Hahn, A., Rieber, E.P., Weiss E., Reithmuller, G. The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brain. J Exp Med 1987, 165: 1230-5.
67. Cheng-Mayer, C., Rutka, J.T., Rosenblum, M.L., McHugh, T., Stites, D.P., Levy, J.A. Human immunodeficiency virus can productively infect cultured human glial cells. Proc Natl Acad Sci USA 1987, 84: 3526-30.
68. Chiodi, F., Fuerstemberg, S., Gidlund, M., Asjo, B., Fenjo, E.M. Infection of brain-derived cells with the human immunodeficiency virus. J Virol 1987, 61: 244-7.
69. Watkins, B.A., Dom, H.H., Kelly, W.B. et al. Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science 1990, 249: 549-53.
70. Kunsch, C., Wigdahl, B. Analysis of nonproductive human immunodeficiency virus type I infection of human fetal dorsal root ganglia glial cells. Intervirology 1990, 31: 147-58.
71. Salahuddin, S.Z., Ablashi, D.V., Hunter, E.A. et al. HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens. Int J Cancer 1987, 30: 198-202.
72. Dreyer, E.B., Kaiser, P.K., Offermann, J.T., Lipton, S.A. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 1990, 248: 364-7.
73. CDC. Classification system of HTLV-III/LAV infections. MMWR 1986, 35: 334-8.
74. CDC. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993, 41: (RR-17).
75. Armstrong, D., Wong, B. Central nervous system infections in immunocompromised hosts. Ann Rev Med 1982, 33: 293-308.
76. Hawley, D.A., Schaefer, J.F., Schulz, D.M., Mullen, J. Cytomegalovirus encephalitis in acquired immunodeficiency syndrome. Am J Clin Pathol 1983, 80: 874-7.
77. Achim, C.L., Nagra, R.M., Wang, R. et al. Detection of Cytomegalovirus in cerebrospinal fluid autopsy specimens from AIDS patients. J Infect Dis 1994, 169: 623-7.
78. Anders, K., Guerra, W., Tomivasu, U. et al. The neuropathology of AIDS: UCLA experience and review. Am J Pathol 1986, 124: 537-58.
79. Petito, C.K., Cho, E.S., Lemann, W. et al. Neuropathology of acquired immunodeficiency syndrome (AIDS): An autopsy review. J Neuropathol Exp Neurol 1986, 45: 635-46.
80. Morgello, S., Cho, E.S., Nielsen, S. et al. Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: An autopsy study of 30 cases and a review of the literature. Hum Pathol 1987, 18: 289-97.
81. Gozlan, J., Salord, J.M., Roullet, E. et al. Rapid detection of cytomegalovirus DNA in cerebrospinal fluid of AIDS patients with neurologic disorders. J Infect Dis 1992, 166: 1416-21.
82. Cinque, P., Vago, L., Brytting, M. et al. Cytomegalovirus infection of the central nervous system in patients with AIDS: Diagnosis by DNA amplification from cerebrospinal fluid. J Infect Dis 1992, 166: 1408-11.
83. Vinters, H.V., Kwok, M.K., Ho, H.W. et al. Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome. Brain 1989, 112: 245-68.
84. Wiley, C.A., Nelson, J.A. Role of human immunodeficiency virus and Cytomegalovirus in AIDS encephalitis. Am J Pathol 1988, 133: 73-81.
85. Belec, L., Gray, F., Mikol, J. et al. Cytomegalovirus encephalomyeloradiculitis and human immunodeficiency virus (HIV) encephalitis: Presence of HIV and CMV coinfected multinucleated giant cells. Acta Neuropathol 1990, 81: 99-104.
86. Navia, B.A., Cho, E.S., Petito, C.K., Price, R.W. The AIDS dementia complex: II. Neuropathoiogy. Ann Neurol 1986, 19: 525-35.
87. Luft, B.J., Castro, K.G. An overview of the problem of toxoplasmosis and pneumocystosis in AIDS in the USA: Implication for future therapeutic trials. Eur J Clin Microbiol Infect Dis 1991, 10: 178-81.
88. Pedrol, E., González-Clemente, J.M., Gatell, J.M. et al. Central nervous system toxoplasmosis in AIDS patients: Efficacy of an intermittent maintenance therapy. AIDS 1990, 4: 511-7.
89. Uberti-Foppa, C., Bini, T., Gregis, G. et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine. Eur J Clin Microbiol Infect Dis 1991, 10: 187-9.
90. Brooks, B.R., Walker, D.L. Progressive multifocal leukoencephalopathy. Neurol Clin 1984, 2: 299-313.
91. Gibson, P.E., Knowles, W.A., Hand, J.F., Brown, D.W. Detection of JC virus DNA in the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Med Virol 1993, 39: 278-81.
92. Moret, H., Guichard, M., Matheron, S., et al. Virological diagnosis of progressive multifocal leukoencephalopathy: Detection of JC virus DNA in cerebrospinal fluid and brain tissue of AIDS patients. J Clin Microbiol 1993, 31: 3310-3.
93. Berger, J.R., Kaszovitz, B., Post, M.J., Dickinson, G. Progressive multifocal encephalopathy associated with human immunodeficiency virus infection. A review of the literature with u report of sixteen cases. Ann Intern Med 1987, 107: 78-87.
94. Snider, W.D., Simpson, D.M., Nielsen, S., Gold, J.W.M., Metroka, C.E., Posner, J.B. Neurological complications of acquired immunodeficiency syndrome: Analysis of 50 patients. Ann Neurol 1983, 14: 403-18.
95. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type I (HIV-1) infection. Neurology 1991, 41: 778-85.
96. Everall, I.P., Luthbert, P.J., Lantos, P.L. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991, 337: 1119-21.
97. Aylward, E.H., Henderer, J.D., McArthur, J.H. et al. Reduced basal ganglia volume in HIV-1-associated dementia: Results from quantitative neuroimaging. Neurology 1993, 43: 2099-104.
98. Dal Pan, G.J., McArthur, J.H., Aylward E.H. et al. Patterns of cerebral atrophy in HIV-1 infected individuals: Results of a quantitative MRI analysis. Neurology 1992, 42: 2125-30.
99. McArthur, J.C., Hoover, D.R., Bacellar, M.A. et al. Dementia in AIDS patients: Incidence and risk factors. Neurology 1993, 43: 2245-52.
100. Vonsattel, J.P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D., Richardson, E.P. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985, 44: 559-77.
101. Khachaturian, Z.S. Diagnosis of Alzheimer's disease. Arch Neurol 1985, 42: 1097-105.
102. Pulliam, L, Herndier, B.G., Tang, N.M., McGrath, M.S. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest 1991, 87: 503-12.
103. Tyor, W.R., Glass, J.D., Griffin, J.W. et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992, 31: 349-60.
104. Bagasra, O., Hauptman, S.P., Lisher, H.W., Sachs, M., Pomerantz, R.J. Detection of human immunodeficiency virus type I provirus in mononuclear cells by in situ polymerase chain reaction. New Engl J Med 1992, 326: 1385-91.
105. Embretson, J., Zupancic, M., Beneke, J. et al. Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single cell resolution. Proc Natl Acad Sci USA 1993, 90: 357-61.
106. Nuovo, G.J., Gallery, F., MacConnell, P., Braun, A. In situ detection of polymerase chain reaction amplified HIV-1 nucleic acids unit tumor necrosis factor-α RNA in the central nervous system. Am J Pathol 1994, 44: 659-66.
107. Price, R.W., Brew, B.J. The AIDS dementia complex. J Infect Dis 1988, 158: 1079-83.
108. Report of the Second Consultation on the Neuropsychiatrie Aspects of HIV-1 Infection. World Health Organization: Geneva 1990.
109. Budka, H. Multinucleated giant cells in brain: A hallmark of AIDS. Acta Neuropathol 1986, 69: 253-8.
110. Tornatore, C.S., Chandra, R., Berger, J., Major, E.O. Infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994, 44: 481-7.
111. Ranki, A., Nyberg, M., Ovod, V. et al. Abundant expression of HIV Nef and Rev proteins in bruin astrocytes in vivo is associated with dementia. AIDS 1995, 9: 1001-8.
112. Epstein, L., Sharer, L.R., Cho, E.S. et al. HTLV-III/LAV like retrovirus particles in the brains of patients with AIDS encephalopathy. AIDS Res Hum Retrovir 1984, 1: 447-54.
113. Sharer, L.R., Epstein, L., Cho, E.S. et al. Pathologic features of AIDS encephalopathy in children: Evidence for LAV/HTLV-III infection of brain. Hum Pathol 1986, 17: 271-84.
114. Pumarola-Sune, T., Navia, B.A., Cordon-Cardo, C. et al. HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol 1987, 21: 490-6.
115. Wiley, C.A., Schrier, R.D., Nelson, J.A. et al. Cellular localization of HIV infection within the brains of AIDS patients. Proc Natl Acad Sci USA 1986, 83: 7089-93.
116. Albright, A.V., Strizki, J., Harouse, J.M., Lavi, E., O'Connor, M., González-Scarano, F. HIV-1 infection of cultured human adult oligodendrocytes. Virology 1996, 217: 211-9.
117. Letvin, N.L., Sehgal, P.K., Hunt, R.D. et al. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 1985, 230: 71-3.
118. Shafer, R.W., Aguiniga, E., Merigan, T.C. Quantitative analysis of syncytium inducing and non-syncytium-inducing virus in patients infected with human immunodeficiency virus type I. J Clin Microbiol 1995, 33: 212-4.
119. Daar, E.S., Chernyavskiy, T., Zhao, J.Q., Krogstad, P., Chen, I.S.Y., Zack, J.A. Sequential determination of viral load and phenotype in human immunodeficiency virus type I infection. AIDS Res Hum Retrovir 1995, 11: 3-9.
120. Ward, J.M., O'Leary, T.J., Baskin, G.B. et al. Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections. Am J Pathol 1987, 127: 199-205.
121. Rosemberg, Z.F., Fauci, A.S. Immunopathogenesis of HIV infection. Faseb J 1991, 5: 2382-90.